Shuichi Nawata

ORCID: 0000-0002-2193-9899
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Treatment and Pharmacology
  • Nausea and vomiting management
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacy and Medical Practices
  • Breast Cancer Treatment Studies
  • Chemotherapy-related skin toxicity
  • Cancer Immunotherapy and Biomarkers
  • Cardiac Ischemia and Reperfusion
  • Eicosanoids and Hypertension Pharmacology
  • Pituitary Gland Disorders and Treatments
  • HER2/EGFR in Cancer Research
  • Pain Management and Opioid Use
  • Nitric Oxide and Endothelin Effects
  • Chemotherapy-induced organ toxicity mitigation
  • Esophageal Cancer Research and Treatment
  • Tryptophan and brain disorders
  • Multiple and Secondary Primary Cancers
  • Bacterial Identification and Susceptibility Testing
  • Health Systems, Economic Evaluations, Quality of Life
  • Inflammatory Biomarkers in Disease Prognosis
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Gastrointestinal motility and disorders
  • Treatment of Major Depression
  • Cutaneous Melanoma Detection and Management
  • Cancer Diagnosis and Treatment

Showa University
1999-2025

Showa University Northern Yokohama Hospital
2018-2025

Showa University Hospital
2023-2025

American Society of Health-System Pharmacists
2024

RELX Group (United States)
2024

Yokohama City University Medical Center
2005-2019

Yokohama City University
2005-2019

Showa Pharmaceutical University
2019

Hoshi University
2003

Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies. Objectives We aimed evaluate clinical characteristics and outcomes heart failure (HF) who compared those matched cohort HF did not receive chemotherapy, using real‐world data. Methods This study was Diagnosis Procedure...

10.1002/ehf2.15204 article EN cc-by-nc-nd ESC Heart Failure 2025-01-13

Skin lesions are prevalent in patients with metastatic colorectal cancer (mCRC) receiving epidermal growth factor receptor (EGFR) inhibitors, such as panitumumab and cetuximab, often necessitating long-term management. Despite adequate treatment involving topical adrenocorticosteroid medications, severe skin may result prolonged or discontinued EGFR inhibitor administration. Consequently, tetracycline antibiotics, their antibacterial anti-inflammatory effects, recommended for...

10.7759/cureus.79261 article EN Cureus 2025-02-18

Medical personnel actively provide patients taking capecitabine with information on the items to prevent and treat hand-foot syndrome (HFS). However, they are typically unable ascertain extent of patient compliance recommended items. Thus, aim present study was association between preventative measures for HFS development HFS. Subjects included 90 who were treated a drug regimen that capecitabine. Patients at one four facilities July 2015 January 2017. The main parameters studied which (or...

10.3892/mco.2018.1689 article EN Molecular and Clinical Oncology 2018-08-02

Introduction Dexamethasone (DEX) is administered for multiple days to prevent chemotherapy-induced nausea and vomiting patients receiving highly emetogenic chemotherapy (HEC); however, its notorious side effects have been widely reported. Although our multicentre randomised double-blind comparative study verified non-inferiority of sparing DEX after day 2 when combined with neurokinin-1 receptor antagonist (NK1-RA) palonosetron (Palo) HEC regimen, was not non-inferior in cisplatin...

10.1136/bmjopen-2020-041737 article EN cc-by-nc BMJ Open 2020-12-01

Background: Association between baseline medications plus neutrophil-to-lymphocyte ratio (NLR) and the effectiveness of immune checkpoint inhibitor (ICI) platinum doublet remains unknown, despite several reported prognostic models. We used real-world data to investigate whether NLR predict survival outcomes in patients with advanced non-small-cell lung cancer (NSCLC) receiving ICI doublet. Methods: This multicenter, retrospective, observational study conducted Japan December 2018 March 2021...

10.7150/jca.80517 article EN cc-by-nc Journal of Cancer 2023-01-01

We formulated mianserin suppositories for the treatment of delirium and evaluated their pharmacokinetics by measuring plasma drug concentrations in dogs healthy human volunteers. Mianserin were prepared a melting technique using Tetramide® tablets Witepsol H-15 as suppository base. Pharmacokinetics this 30-mg preparation three beagle adult males, line with ethics committee approval. Plasma levels determined gas chromatography–mass spectrometry. In dogs, maximum concentration (Cmax) was 1.3 ±...

10.1186/s40780-016-0046-7 article EN cc-by Journal of Pharmaceutical Health Care and Sciences 2016-05-03

Pembrolizumab monotherapy significantly extends progression-free and overall survival compared to platinum-based chemotherapy for advanced non-small cell lung cancer (NSCLC), but also has a significant impact on medical costs. To clarify the health economic evidence selecting first-line treatment patients with stage IV NSCLC programmed death ligand 1 tumor proportion score of 50% or greater in Japan, we assessed cost-effectiveness pembrolizumab that chemotherapy. Using Markov model, study...

10.1007/s11096-024-01826-7 article EN cc-by-nc-nd International Journal of Clinical Pharmacy 2024-11-20

An injectable medicine dispensing system based on an auto ampule (AAD) was introduced at Yokohama City University Medical Center. We made a drug interaction check list and dose for pediatrics which to base inquiries concerning prescriptions medicines inpatients over three-year period, investigated the effectiveness of interventions resulting from them. There were total 865 number increased 1.5-fold after residents reassigned. Inquiries accounted approximately 66% total.The five main clinical...

10.5649/jjphcs.31.707 article EN Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2005-01-01

1047 Background: Taxane-based regimens have been widely used to treat breast cancer. Accordingly, it has become important identify subgroups in which anthracyclines are indispensable. Thus, we initiated a randomized phase II neoadjuvant chemotherapy (NAC) study compare taxane with and without anthracycline hormone-negative subtypes. Methods: Eligibility criteria were hormone-negative, an age younger than 80 years ECOG PS0-1. According HER2 status, patients randomly assigned TC (75/600 mg/m 2...

10.1200/jco.2013.31.15_suppl.1047 article EN Journal of Clinical Oncology 2013-05-20

【目的】入院患者のための麻薬自己管理システムを構築し, その有用性を検討した. 【方法】院内医療スタッフへのアンケート結果をふまえ, 多職種によるワーキンググループで麻薬自己管理の患者条件と方法を定めた. 対象は, (1)内服薬自己管理アセスメント適合, (2)麻薬自己管理アセスメント適合, (3)医師の同意あり, (4)患者の希望あり, の4条件を満たした患者とした. また, 自己管理を実施した患者および医療スタッフにアンケートを行った. 【結果】2008年4月より12カ月間に内外用の麻薬施用の入院患者は100名おり, 麻薬自己管理可能患者は26名, そのうち患者希望で実施したのは20名であった. 自己管理中(平均15.0日間)に紛失, 盗難, 誤服用はなかった. 実施患者の94%は, 手元に薬があって安心, 困ったことはないと答えた. スタッフは75%が自己管理を継続すべきと答えた. 【結語】当システムは病棟での安全で適切な麻薬自己管理実施に有用と示唆された. Palliat Care Res 2010; 5(1): 114-126

10.2512/jspm.5.114 article EN Palliative Care Research 2010-01-01

Mianserin suppositories were formulated to treat symptoms of delirium and depression. Pharmacokinetics assessed by measuring blood concentrations mianserin in healthy older Japanese male adults. The effects 20 mg evaluated three concentration was measured using gas chromatography-mass spectrometry. tmax 14.7±8.1 h; Cmax 7.0±1.4 ng/mL; AUC0−48 196.7±19.6 h・ng/mL; AUC0−∞ 264.9±38.3 h・ng/mL. Compared young adults, adults demonstrated delayed tmax, lower Cmax, AUC0−∞, suggesting a absorption...

10.3999/jscpt.50.23 article EN Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 2019-03-30

The standard of care for ovarian cancer chemotherapy is paclitaxel-carboplatin. In Stage III and IV patients, the addition bevacizumab has been reported to be effective, combined with paclitaxel-carboplatin docetaxel-carboplatin are used. Patients who received experienced a high incidence skin hardening followed by peeling. patients treated docetaxel-carboplatin, we post-sclerotic peeling skin, symptom that rarely seen (TC), (DC), or paclitaxel-carboplatin, in few cases. Therefore,...

10.1007/s13691-022-00576-5 article EN cc-by International Cancer Conference Journal 2022-09-25

Yokohama City University Medical Center has employed an auto ampule dispensing system (AAD) for injectable medicines connected to a computer order entry since 2000. AAD is able pick up the appropriate ampules and vials according prescription each inpatient's prescription. After employing this system, opportunity patients inquire about prescriptions increased.In study, we focused our attention on of H2-receptor antagonist (H2-B) proton pump inhibitor (PPI) from pharmacist's standpoint...

10.5649/jjphcs.29.593 article EN Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2003-01-01

Abstract Purpose To identify the processes of cancer-related pain relief and exacerbation faced by outpatients in an acute care hospital to examine support needed for outpatient control. Methods We conducted semi-structured, in-depth interviews with patients from department Showa University Northern Yokohama Hospital Kanagawa Prefecture, Japan. Participants were recruited purposive sampling. From recorded data, verbatim transcripts made used as textual data analysis consistent comparative...

10.1186/s12904-023-01236-y article EN cc-by BMC Palliative Care 2023-08-01

Cisplatin therapy induces kidney injury as a side effect. Thus, replacement fluid must be administered to prevent injury. In our hospital, we use Gemcitabine and combination chemotherapy (GC) at total volume of approximately 500 mL for biliary tract cancer. We investigated the safety GC with small amount fluid. As result, no serious adverse events renal occurred that required discontinuation treatment. The median overall survival time was 260 d (95% confidence interval, 154-367 d). This...

10.1248/yakushi.19-00223 article EN YAKUGAKU ZASSHI 2020-06-30

がん性疼痛に対してオキシコドン塩酸塩を使用している妊婦症例を経験する機会は極めて少ない.今回,長期にオキシコドン塩酸塩を使用した妊婦を経験した.妊娠経過中は,オキシコドン塩酸塩使用による妊娠経過への悪影響はなく,胎児の発育も順調であった.しかし,児は出生直後に無呼吸発作が出現し,人工呼吸器管理が必要となった.また,新生児薬物離脱症候群に対する薬物治療を必要とした.

10.2512/jspm.15.297 article JA Palliative Care Research 2020-01-01
Coming Soon ...